Booklet Updates

A listing of FDA drug approvals by disease.

The Leukemia & Lymphoma Society wants you to have the most up-to-date information about blood cancer treatment. See below for new treatments that have been FDA approved since these booklets were printed. 

For more information, contact an Information Specialist at (800) 955-4572 or infocenter@lls.org.
 

Booklet Titles by Disease/Topic

To access drug updates for these booklets, click on the red disease headings.

Leukemia

  • Acute Lymphoblastic Leukemia (ALL ) in Adults (November 2024)
  • Acute Lymphoblastic Leukemia (ALL) in Children and Teens (June 2024)
  • The ALL Guide: Information for Patients and Caregivers (November 2024)
  • Acute Myeloid Leukemia in Adults (July 2023)
  • Acute Myeloid Leukemia in Children and Teens (No updates)
  • The AML Guide: Information for Patients and Caregivers (July 2023)
  • ​Chronic Lymphocytic Leukemia​ (March 2024)
  • The CLL Guide: Information for Patients and Caregivers (March 2024)
  • Chronic Myeloid Leukemia​​ (September 2023)
  • The CML Guide: Information for Patients and Caregivers​ (September 2023)

Lymphoma

  • Cutaneous T-Cell Lymphoma (August 2024)
  • Hodgkin Lymphoma: No updates
  • Non-Hodgkin Lymphoma (June 2024)
  • The Lymphoma Guide: Information for Patients and Caregivers (June 2024)

Myeloma

  • Myeloma (April 2024)
  • The Myeloma Guide: Information for Patients and Caregivers (April 2024)

​Myelodysplastic Syndromes

  • ​​Myelodysplastic Syndromes  (June 2024)
  • The MDS Guide: Information for Patients and Caregivers  (June 2024)

​Myeloproliferative Neoplasms

  • Myeloproliferative Neoplasms (September 2023)

Treatment

  • Blood and Marrow Stem Cell Transplantation (Updated April 2023)
  • Blood and Marrow Stem Cell Transplantation Guide (Updated April 2023)


 

Other Languages